Quaternary ammonium compounds (QAC) are widely used, cheap, and chemically stable disinfectants and topical antiseptics with wide-spectrum antimicrobial activities. Within this group of compounds, we recently showed that there are significant differences between the pharmacodynamics of n-alkyl quaternary ammonium surfactants (QAS) with a short (C 12 ) alkyl chain when in vitro toxicities toward bacterial and mammalian epithelial cells are compared. These differences result in an attractive therapeutic window that justifies studying short-chain QAS as prophylactics for sexually transmitted infections (STI) and perinatal vertically transmitted urogenital infections (UGI). We have evaluated the antimicrobial activities of short-chain (C 12 ) n-alkyl QAS against several STI and UGI pathogens as well as against commensal Lactobacillus species. Inhibition of infection of HeLa cells by Neisseria gonorrhoeae and Chlamydia trachomatis was studied at concentrations that were not toxic to the HeLa cells. We show that the pathogenic bacteria are much more susceptible to QAS toxic effects than the commensal vaginal flora and that QAS significantly attenuate the infectivity of N. gonorrhoeae and C. trachomatis without affecting the viability of epithelial cells of the vaginal mucosa. N-Dodecylpyridinium bromide (C 12 PB) was found to be the most effective QAS. Our results strongly suggest that short-chain (C 12 ) n-alkyl pyridinium bromides and structurally similar compounds are promising microbicide candidates for topical application in the prophylaxis of STI and perinatal vertical transmission of UGI.
D
espite advances in modern medical care, sexually transmitted infections (STI) and perinatal urogenital infections (UGI) are major global causes of illness, infertility, and death (1) . If left untreated, curable STI are known to facilitate HIV infection and transmission (2) and are also intimately associated with congenital and perinatal infections in neonates (3) . In recent years, the significant increase in multidrug-resistant pathogens, together with the lack of effective vaccines, makes the prevention of STI a challenge. Currently available options for prevention of STI are essentially restricted to condoms (4) , but limited economic resources and gender inequality may narrow women's ability to negotiate consistent condom use with their sexual partners. Safe and effective topical microbicides, such as vaginal gels, represent one of the most promising prevention strategies. Perinatal vertically transmitted UGI are also canonically prevented by timely screening and antibiotic treatments of pregnant women, but the enforceability of these procedures is very dependent upon the socioeconomic context. A one-time use of topical microbicides may offer a prophylactic solution for intrapartum transmission of UGI from the mother to the neonate (5), particularly in those cases in which canonical antibiotic treatments are either not available or not adequately carried out. The microbicidal activity of quaternary ammonium compounds (QAC) makes these compounds attractive and cheap prophylactic alternatives (6) .
All surfactants are toxic to all cells at concentrations that cause membrane dissolution, but selective toxicity at lower concentrations to bacterial cells, as opposed to mammalian epithelial cells, is observed only for quaternary ammonium surfactants (QAS), a subfamily of the QAC (7, 8) . We have recently reported detailed studies on the mechanisms of QAS toxicity to mammalian (9) and bacterial (8) cells at concentrations at which cell membrane dissolution does not occur. Our results indicated that while QAS toxicity to mammalian cells was primarily due to surfactant-induced mitochondrial dysfunction (9) , the toxic action on bacteria was considerably more complex (8) , involving impairment of bacterial energetics and cell division at low concentrations and membrane permeabilization and electron transport inhibition at slightly higher doses. From the perspective of concentration dependence of QAS toxicity, the differences between mammalian and bacterial cells is more pronounced for the short-chain QAS, contrary to what is frequently stated in the literature (10) . QAS having n-alkyl groups with 10 to 12 carbons discriminate better between the host cells and the pathogens than do their respective homologues with 14 to 16 carbons (7, 8) and offer a sufficiently large therapeutic window to merit research on their use as topical vaginal antiseptics.
Here, we have expanded our studies on (C 12 ) n-alkyl QAS an-timicrobial properties and examined their activity against several STI and UGI pathogens as well as against commensal Lactobacillus species. Three analogous n-alkyl-QAS families, pyridinium bromide (PB), benzyl-dimethylammonium bromide (BZK), and trimethylammonium bromide (TAB), with the same (C 12 ) n-alkyl chain were compared. The reasoning that led to the choice of these analogues has been discussed in previous work (7) (8) (9) 11) . We show that the studied pathogenic bacteria are much more susceptible to QAS toxic effects than the commensal vaginal bacterial flora and vaginal mucosa cells. C 12 PB was found to be the most effective among the QAS tested. More importantly, besides reducing the capacity for primary infection (first-round infectivity), QAS also significantly attenuated the second-generation infectivity of Chlamydia trachomatis and reduced the viability of the gonococci that were capable of infecting HeLa cells.
MATERIALS AND METHODS
Reagents. QAS of the highest commercially available purity, N-dodecylpyridinium bromide (C 12 PB), N-dodecyltrimethylammonium bromide (C 12 TAB), and N-dodecyl-N-benzyl-N,N-dimethylammonium bromide (C 12 BZK), were purchased from Sigma-Aldrich and used as received. All mammalian cell culture reagents and Hanks' balanced salt solution (HBSS) were purchased from Gibco Life Technologies S.A, agaragar was obtained from Merck, Todd-Hewitt broth was from Difco, and the Trichomonas medium no. 2, Lactobacilli MRS agar plates, and Lactobacilli MRS broth were from Oxoid. Chocolate agar PolyViteX and Columbia agar plus 5% sheep blood agar were purchased from bioMérieux. Anti-Neisseria gonorrhoeae conjugated with fluorescein isothiocyanate (FITC) (ab20815) and anti-MOMP (major outer membrane protein of C. trachomatis strain L2) antibodies were obtained from Abcam, and antitubulin (clone B-5-1-2) was from Sigma-Aldrich. Secondary fluorescent antibodies were from Molecular Probes Invitrogen Corporation or Jackson ImmunoResearch Laboratories. All other chemicals used were from Sigma-Aldrich. Microorganism strains, growth conditions, and antimicrobial susceptibility. A total of 21 microorganisms (listed in Table 1 ) were examined. All isolates belong to the stock culture collection of the STI reference laboratory from the Portuguese National Institute of Health, unless stated otherwise. Before each experiment, frozen stocks of all strains were subcultured at least once to check strain viability, and inocula were prepared accordingly. Briefly, for Trichomonas vaginalis, each frozen stock was first centrifuged at 3,000 rpm for 5 min at 24°C before being cultured in fresh sterile medium at 35°C, and inocula of 1.275 ؋ 10 6 cells/ml were prepared directly from each 48-h subculture. For the fastidious bacteria Neisseria gonorrhoeae, Streptococcus agalactiae, and Lactobacillus spp., each inocu- (12, 13) , using a 1:20 dilution of the prepared inoculum for all microorganisms, except for T. vaginalis, for which a 1:10 dilution was used. Twofold serial dilutions of concentrated stock QAS solutions (0.4 to 1.6 mM) were prepared in the required medium into 96-well plates. A control without QAS was also prepared. All cultures were incubated for 18 to 48 h in an orbital shaker (200 rpm) at 35 to 37°C with 5% CO 2 . Purity check and colony or viable cell counts of the inoculum suspensions were also evaluated in order to ensure that the final inoculum density closely approximates the intended number. The MIC was determined as the lowest QAS concentration at which no visible growth was observed. Optical densities were measured at 600 nm, except for T. vaginalis, for which microscopic observation was performed. These assays were done in triplicate.
Cell culture and MTT assay. HeLa 229 cells (ATCC CCL-2.1) were seeded in 96-well plates and grown in Dulbecco's modified Eagle medium (DMEM) with GlutaMAX, supplemented with 10% fetal bovine serum (FBS), 100 units/ml of penicillin, and 100 g/ml streptomycin, at 37°C in 5% CO 2 for 24 h, when they reached confluence. The End1/E6E7 immortalized human endocervical epithelial cell line (14) was kindly provided by Raina Fichorova of the Brigham and Women's Hospital, Harvard Medical School (Boston, MA, USA). Cells were maintained in keratinocyte serumfree medium supplemented with 50 g/ml bovine pituitary extract, 0.1 ng/ml human transferrin, and CaCl 2 to a final concentration of 0.4 mM. Cells were seeded in 96-well plates and grown until confluence (ϳ24 h) at 37°C in 5% CO 2 . The cells were then incubated with increasing QAS concentrations for 1 h. Stock solutions of surfactants were prepared in Opti-MEM cell culture medium, without serum and antibiotics, as multiples of the respective critical micelle concentration (CMC) (11) . At the end of the incubation, QAS-containing medium was replaced by fresh complete culture medium without phenol red. Cell viability was assessed immediately or 24 h after exposure to QAS by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay (15) . The samples were quantified colorimetrically at 570 nm (background wavelength correction at 620 nm) on a SpectraMax Plus384 microplate spectrophotometer (Molecular Devices Inc.). The background absorbance (culture medium plus MTT without cells) was subtracted from the absorbance of each sample, and data are shown as percentages of control. Doseresponse toxicity curves were fitted using the Hill equation (16), through computer-assisted curve fitting (SigmaPlot 11.0). From these analyses, it was possible to calculate the 10% inhibitory concentration (IC 10 ; i.e., the concentration at which cell viability was 10% of that of the control), IC 50 , and IC 90 for each data set.
Infection of epithelial cells with N. gonorrhoeae. Gonococcal infection assays were performed by a standard method (17, 18) , with slight modifications. HeLa cells were grown in glass coverslips or in 48-well plates until reaching confluence. After that, cells were washed and cell culture medium was replaced by Opti-MEM serum-and antibiotic-free culture medium. N. gonorrhoeae PT07-15 cells from a 24-h plate were resuspended in Opti-MEM to achieve a final multiplicity of infection (MOI) of 100. Bacteria were allowed to adhere for 1 h at 37°C in a CO 2 incubator, in the presence or absence of each of the QAS. Cells were then washed with PBS, followed by 3 h of incubation with DMEM supple- mented with 10% FBS at 37°C and 5% CO 2 , to allow the internalization of the attached bacteria. For fluorescence cell imaging assays, cells were fixed with ice-cold methanol for 10 min and immunolabeled with an anti-N. gonorrhoeae FITC antibody. Images were taken in a Carl Zeiss laser scanning confocal microscope LSM 510. The percentage of infected cells and the number of infecting particles per infected cell were determined and compared with the values for untreated controls. To assay for bacterial invasion and evaluate the viability of the gonococci that were capable of infecting host cells, cell monolayers were washed with PBS, followed by the addition of 100 l of PBS supplemented with 0.5 mM EDTA to each well. Cells were scraped off and collected, vortexed vigorously for 1 min, serially diluted, spread on chocolate agar plates, and incubated for 48 h at 37°C in a CO 2 incubator. CFU were counted to determine the number of viable bacteria. Data are presented as CFU/10 5 epithelial cells. Infection of epithelial cells by C. trachomatis. C. trachomatis L2/ 434/Bu (ATCC VR-902B) was propagated in HeLa cells using standard techniques (19) . To test the effect of the QAS on C. trachomatis in vitro infection, HeLa cells seeded the day before on 24-well plates were equilibrated in HBSS and incubated at 37°C with C. trachomatis for 1 h at an MOI of 5, in the presence or absence of each of the QAS. The cells were then washed with culture medium containing 10 g/ml gentamicin, but without penicillin or streptomycin, and incubated in this medium at 37°C. At 24 h postinfection, cells that had been seeded on glass coverslips were fixed with methanol for 5 min at Ϫ20°C and processed for immunofluorescence microscopy using monoclonal antibodies against the major outer membrane protein (MOMP), to enable the estimation of the number of infected cells and the volume of the vacuoles enclosing C. trachomatis. At 44 h postinfection, the number of infectious C. trachomatis progeny present was estimated after osmotic lysis of the infected cells with H 2 O, followed by serial dilutions of the lysates in sucrose-phosphateglutamate buffer that were used to infect HeLa cells seeded the day before on glass coverslips in 24-well plates. After 24 h of infection, the cells were fixed in methanol for 5 min at Ϫ20°C and immunolabeled as described above. Inclusions in 20 to 25 fields of view were counted in the appropriate dilutions (10 to 50 inclusions per field of view) using a Leica DMRA2 microscope with a 40ϫ objective (numerical aperture [NA], 0.75). Inclusions per field of view were transformed into inclusion-forming units (IFU) per milliliter (19) .
Morphometric analysis of chlamydial inclusions was carried out in confocal optical sections of cells labeled with an anti-MOMP C. trachomatis antibody. Image acquisitions were made in a confocal microscope with an EC-PlanNeofluor 40ϫ oil immersion objective (NA, 1.30) using the Carl Zeiss laser scanning system LSM 510 software. Surface rendering was carried out in 5-to 12-m z-stack images composed of 0.7-m optical slices using Imaris (Bitplane AG). The volume of C. trachomatis inclusions was calculated from this volumetric reconstruction. , and 90% inhibitory concentration (IC 90 ), i.e., surfactant concentrations at which cell viability was, respectively, 10%, 50%, and 90% of that of the control for each time point, were calculated from the theoretical curves adjusted to the dose-response toxicity plots.
RESULTS
Antimicrobial activity of short-chain n-alkyl QAS. In order to evaluate the antimicrobial activity of QAS against bacteria involved in STI and UGI, we determined the MICs of C 12 PB, C 12 BZK, and C 12 TAB for several Streptococcus agalactiae (Grampositive) and N. gonorrhoeae (Gram-negative) strains. The MICs for these compounds were also determined for some microorganisms of the commensal vaginal flora. In previous work (7, 8, 11) , we have argued that the effective biocidal concentrations of QAS should be compared after normalization relative to their respective CMC. In what follows, we shall, therefore, compare the efficacy of different QAS using the CMC-normalized MIC (MIC/CMC) values. The rationale for reporting effective QAS concentrations as CMC-normalized values is explained in more detail in the supplemental text. CMC values for the QAS used have been previously reported by us (11) . Using this definition, the relative antibacterial efficacy was C 12 PB Ͼ C 12 BZK Ͼ C 12 TAB (Table 2 ). While the toxicity pattern was similar to that previously described for Escherichia coli (8) , QAS were more effective against the pathogenic bacteria tested, regardless of being Gram-positive or Gram-negative. For the majority of the analyzed strains, the PB analogue was at least two times more effective in inhibiting bacterial growth than the BZK and TAB analogues. In contrast, the tested commensal Lactobacillus spp. were more resistant to QAS effects and no correlation between the antibacterial activity and QAS polar head structure was found (MIC/CMC ratios were the same or within a range of 1 dilution). The biocidal activity of QAS against the protozoan STI/UGI parasite Trichomonas vaginalis was also examined. In this case, the inhibitory effectiveness rank of the QAS examined was C 12 PB Ͼ C 12 BZK Ϸ C 12 TAB. The MIC/CMC values obtained, however, were two to four times higher for T. vaginalis than for the most resistant bacterium, Lactobacillus jensenii, suggesting that QAS would be less useful in the prevention of protozoan STI/UGI than of bacterial STI/UGI.
Toxicity of short-chain n-alkyl QAS to vaginal epithelial cells. As infections with C. trachomatis and N. gonorrhoeae are the most common bacterial STI and the most prevalent coinfections with HIV (1, 2), we studied the potential of QAS to inhibit these infections using an in vitro model. The primary target for bacterial and viral STI in women is the nonkeratinized squamous epithelium of the vagina and ectocervix, as well as the single-layer columnar epithelium of the endocervix. Thus, the End1 immortalized epithelial cell line from normal human endocervical tissue and HeLa epithelial cells originating from an adenosquamous carcinoma of the cervix were used as models of female lower genital tract epithelial cells. It has been shown that both cell lines support chlamydial growth (20, 21) as well as the attachment and intracellular uptake of piliated N. gonorrhoeae strains (17, 18) .
In in vitro experiments that study the invasion of human host cells in culture by a pathogen, the concentration of the antiseptic agent used (in our case, QAS) must always be subtoxic to the host cells used, in our case End1 and HeLa cells. It was therefore important to determine the toxicity curves of QAS for End1 and HeLa cell cultures. This was done by evaluating the effects of QAS on the viability of End1 and HeLa cell lines using the MTT assay immediately or 24 h after exposure to increasing surfactant concentrations for 1 h (Fig. 1A to C) . Consistent with our previous results (9, 11) , exposure to QAS resulted in a persistent postexposure toxicity as can be seen by the low inhibitory concentrations 24 h postexposure compared to those observed immediately after the end of incubation. The QAS toxicity ranking for both cell lines was C 12 PB Ϸ C 12 BZK Ͼ C 12 TAB. Despite the fact that, contrary to HeLa cells, End1 cells can be fully polarized in vitro, resembling the morphological characteristics of epithelial cells of the vaginal mucosa (14) , maturity of tight junctions is achieved only after 8 to 10 days in culture (22) . Consequently, under our experimental conditions, End1 cells lack mature nonleaky tight junctions, justifying the similar IC 50 s determined for End1 and HeLa cells. Since no significant differences in QAS susceptibility of these two cell lines were observed, further experiments were performed in HeLa cells as this cell line is easier to grow and maintain in culture. In previous work (8), we showed that the therapeutic indices (determined using a fully polarized columnar epithelial cell line) after 60 min of exposure to C 12 PB were ϳ10 for a multidrug-resistant strain of E. coli and Ͼ20 for the most resistant strain of N. gonorrhoeae tested. Nonpolarized epithelial cells are more susceptible to QAS toxicity than fully polarized columnar epithelial cell lines, in which the tight junctions are well formed (11), so it is expected that the therapeutic indices are somewhat lower in the case of the nonpolarized cells. Nevertheless, they are useful practical models for infectivity. Therefore, in what follows, HeLa cells were used and the QAS concentrations were always lower than those that were toxic to HeLa cells.
Effect of QAS on N. gonorrhoeae infectivity. Invasion of HeLa cells by N. gonorrhoeae and its attenuation by C 12 PB are shown in Fig. 2 . Although C 12 PB apparently had a very small effect on the percentage of infected cells at the concentrations tested ( Fig. 2A  and B) , a significant reduction in gonococcal invasion was detected, as indicated by the lower numbers of internalized bacteria ( Fig. 2A and C) . In the absence of C 12 PB (control) the average number of infecting particles per infected cell was 12.6, whereas in cells treated with C 12 PB it was only 4.3 at a concentration of CMC/ 150 (P Ͻ 0.001). In order to evaluate the viability of the gonococci that were capable of infecting host cells, N. gonorrhoeae-infected HeLa cells were lysed 3 h postinfection and lysates were diluted and spread onto agar plates to estimate the number of recovered CFU per epithelial cell. As shown in Fig. 2D , a C 12 PB concentration as low as CMC/500 reduced the number of CFU recovered by a factor of 1,000 and at CMC/150 by 10,000. The results obtained for C 12 BZK were similar to those of C 12 PB (Fig. 2E to G higher concentrations being necessary to achieve comparable results ( Fig. 2H to J) .
Effect of QAS on C. trachomatis infectivity. C. trachomatis replicates exclusively within host cells in a membrane-bound vacuole, the inclusion, undergoing a developmental cycle whereby it alternates between the infectious, but nonreplicative, elementary bodies (EBs) and the noninfectious, but replicative, reticulate bodies (23) . To understand if QAS interfere with the Chlamydia infectious cycle, HeLa cells were inoculated for 1 h with C. trachomatis strain L2/434, in the absence or presence of QAS concentrations that were previously determined to be subtoxic for the HeLa cells. The strain of C. trachomatis that we used is widely used in studies of Chlamydia-host cell interactions. Although infections caused by this serovar are less common than those caused by other strains and the pathogenicity profiles of the different serovars are distinct, they all share 98% identity at the nucleotide level. Hence, there is no reason to expect that the surfactants would behave differently toward distinct C. trachomatis serovars in a tissue culture model of infection.
Analysis of the number of infected cells 24 h postinfection showed that C 12 PB inhibited the infection of HeLa cells by C. trachomatis in a dose-dependent manner, as seen by a decrease in the percentage of cells bearing visible inclusions, from 56.9% Ϯ 5.9% under control conditions to 27.6% Ϯ 14.9% at CMC/150 ( Fig. 3A and B) . Additionally, cultures that had been incubated with C 12 PB resulted in inclusions with a much smaller size (Fig. 3A and C), strongly suggesting that C 12 PB inhibits the intracellular growth of C. trachomatis. In fact, at CMC/150, inclusions are difficult to find due to their abnormally small size.
The effects of C 12 PB on the formation of C. trachomatis infectious progeny (EBs) were also investigated. Cells infected in the absence or presence of QAS were lysed 44 h postinfection, and lysates were used to infect freshly seeded cells. Twenty-four hours after secondary infection, quantification of recovered IFUs was performed. As can be seen in Fig. 3D , C 12 PB significantly decreased the formation of C. trachomatis infectious progeny, showing a substantial reduction in the recovered IFUs (in the worst case from six independent experiments, at least by a factor of 10 at CMC/500, while the mean value of the recovered IFUs showed a reduction of 7 orders of magnitude), a much stronger effect than that observed for the primary infection. At higher concentrations (i.e., CMC/300 and CMC/150), secondary infection was virtually abolished (for both concentrations in five of six independent experiments, no IFUs were recovered). In contrast, while the results obtained for C 12 BZK regarding the percentage of infected cells were similar to those of C 12 PB, C 12 BZK was less effective in inhibiting the formation of C. trachomatis infectious progeny in the same concentration range (Fig. 3E to G) . C 12 TAB was also less effective in attenuating chlamydial infection, similar to what was observed for N. gonorrhoeae infectivity, and higher concentrations were necessary to achieve similar results (Fig. 3H to J) . As discussed in some detail by us earlier (8), we believe the differences between the PB and the TAB/BZK derivatives to be a consequence of the delocalized positive charge in the polar head group of C 12 PB that facilitates its translocation across the membranes of the host cells, exposing the invading infectious agents for an effectively longer time to this QAS.
DISCUSSION
The urgent need for woman-controlled, safe, and effective topical microbicides for the prevention of STI makes QAS-containing formulations an interesting option, since QAS have a well-known antimicrobial activity, combined with a low price and excellent chemical stability. Topical microbicides could also be a prophylactic solution for perinatal vertically transmitted UGI. Motherto-child transmission of UGI can be prevented by screening pregnant women for these infections and providing antibiotic treatment to them before term or during childbirth. Yet, one major problem with these infections is their discontinuous nature: the mother can be infected at the time recommended for screening and no longer when going into labor or vice versa. In the first scenario, the canonical treatment and consequent protection will be provided, whereas in the second it will not. Additionally, when the canonical preterm protocols for pregnant women are not rigorously adhered to, a last-recourse prophylactic antiseptic treatment at term may be recommendable in order to avoid, or attenuate, the probability of vertical transmission. Potentially, the routine use of a microbicide gel immediately prior to term could dispense screening and unnecessary use of antibiotics while eliminating, or at least significantly attenuating, the risk of infection, but this will require further work in vivo. This aspect is of particular relevance in places where the standard procedures used in "developed" countries are either not available or not rigidly adhered to.
The results reported in the present paper show that the pathogenic bacteria analyzed were much more susceptible to QAS toxic effects than commensal Lactobacillus species. This difference in QAS susceptibility is of particular importance since lactobacilli are women's predominant members of the commensal vaginal flora (24) , playing a central role in the maintenance of a low vaginal pH and contributing to avoid colonization of the urogenital tract by pathogenic bacteria (25, 26 ). An acidic vaginal pH has also been correlated with a decrease in HIV infection (27, 28) . Recent studies employing cultivation-independent molecular approaches showed that the vaginal microbiome (VMB) is much more complex than previously appreciated and that conventional culture techniques are limited, allowing the detection of only a small fraction of the microorganisms in the vaginal flora (29, 30) . Therefore, detailed studies on the effects of QAS on the VMB, employing genetically controlled ex vivo models in combination with cultivation-independent methods (31, 32) , should be performed in the future. This kind of approach will allow a more detailed analysis of the effects of QAS not only on healthy VMB but also on dysbiotic VMB collected from patients with bacterial vaginosis (32) , the most common cause of vaginal infection in women of childbearing age, a main factor of increased susceptibility to infection by HIV and other STI (29) . QAS, being neutral salts, will not alter vaginal pH directly, but indirect effects through alterations of the VMB cannot be excluded at this stage. Yet other important considerations are the effects of long-term exposure to QAS, their potential to act as inflammatory agents, and the likelihood of bacteria developing resistance (or coresistance to other antibiotics). While these aspects need to be assessed in future studies, the results reported in this paper suggest that short-chain QAS should be regarded as potentially valuable topical microbicides.
Of the QAS analyzed, C 12 PB was found to be the most effective, which is in agreement with our previous results for E. coli (8) . In addition, QAS were shown to attenuate C. trachomatis and N. gonorrhoeae infections at very low concentrations that do not affect the viability of nonpolarized host epithelial cells in vitro. More importantly, the decrease in pathogen infectivity is even greater when the secondary infectivity of these pathogens is considered. This suggests not only that a one-time application could reduce the risk of vertical transmission of infection but also that repeated topical application of C 12 PB may have a curative potential for established infections by both N. gonorrhoeae and C. trachomatis without recourse to systemic antibiotic treatment.
